Update on schizophrenia and bipolar disorder: focus on cariprazine [PDF]
Neuropsychiatric Disease and Treatment, 2016 Rona Jeannie Roberts,1 Lillian Jan Findlay,2 Peggy L El-Mallakh,2 Rif S El-Mallakh1 1Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, 2School of Nursing ...
Roberts RJ +3 more
doaj +2 more sources
Beyond the Block: Cariprazine in Treatment-Resistant Depression [PDF]
Eur PsychiatryIntroduction Treatment-resistant depression (TRD) remains one of the most challenging conditions in psychiatry, particularly when accompanied by psychotic features.
Grahovac Juretić T +4 more
europepmc +2 more sources
Effect Of Cariprazine On Metabolic Parameters In Patients Living With Major Depressive Disorder: A Systematic Review And Meta-Analysis [PDF]
Eur PsychiatryIntroduction Cariprazine is a second-generation antipsychotic approved for treating schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and as adjunctive treatment in major depressive ...
Pompili M +6 more
europepmc +2 more sources
CLINICAL POTENTIAL OF CARIPRAZINE IN THE TREATMENT OF ACUTE MANIA [PDF]
, 2013 Cariprazine (RGH-188, trans-4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexyl-aminehydrochloride), is a novel antipsychotic with dopamine D2 and D3 receptors antagonist-partial agonist properties.
Oral, Esat Timucin +2 more
core +10 more sources
Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series [PDF]
Neuropsychiatric Disease and Treatment, 2022 Juan D Duque-Yemail,1 Juan Carlos Avila2 1Psychiatry Resident, Department of Mental Health, Vall d’Hebron University Hospital, Barcelona, Spain; 2Psychiatrist, Mental Health Center, Badalona, SpainCorrespondence: Juan D Duque-Yemail, Vall d’Hebron ...
Duque-Yemail JD, Avila JC
doaj +2 more sources
Gender-specific symptom outcomes on cariprazine treatment: a 12-month naturalistic longitudinal follow-up study in schizophrenia [PDF]
Frontiers in PsychiatryIntroductionA growing body of literature is focusing on third-generation antipsychotics and their unique characteristics, but few studies have examined gender as a crucial factor in response profiles.
Claudia Carmassi +8 more
doaj +2 more sources
Symptomatic Profile of Cariprazine in the Context of ICD-11 Domains for Schizophrenia: Review of Clinically Oriented Studies [PDF]
Consortium Psychiatricum, 2022 INTRODUCTION: One of the innovations in the ICD-11grouping "Schizophrenia and Other Primary Psychotic Disorders" is the implementation of six symptom domains intended to improve diagnostics and treatment of these mental conditions in clinical practice ...
Alexey Viktorovich Pavlichenko +1 more
doaj +1 more source
Therapeutics and Clinical Risk Management, 2015 Felix-Martin Werner,1,2 Rafael Coveñas2 1Euro Akademie Pößneck, Higher Vocational School for Elderly Care and Occupational Therapy, Pößneck, Germany; 2Institute of Neurosciences of Castilla y León (INCYL), Laboratory ...
Werner FM, Coveñas R
doaj +1 more source
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review [PDF]
Therapeutic Advances in PsychopharmacologyCariprazine is effective in a number of conditions and has shown efficacy in the treatment of negative symptoms. Data on its use as an adjunct to other antipsychotics is growing.
Ewa Okon-Rocha, David Taylor
doaj +2 more sources
Cariprazine‐induced mania: A case series report [PDF]
, 2022 Bipolar depression is the most prevalent phase of bipolar disorder (BD). There is a risk of inducing treatment-emergent affective switches (TEAS) with antidepressants (ADs).
Anmella, Gerard +37 more
core +1 more source